Compare Stocks: SCLX, NMHI, IBM, and DVLT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DVLT Datavault AI	$0.32 +0.8%	$0.35	$0.25 ▼ $4.10	$299.17M	0.31	48.05 million shs	4.63 million shs
IBM International Business Machines	$232.48 +0.6%	$246.44	$199.19 ▼ $332.46	$218.85B	0.7	7.94 million shs	534,145 shs
NMHI Nature's Miracle	$0.00	$0.00	$0.00 ▼ $0.46	$503K	0.68	24.80 million shs	4.88 million shs
SCLX Scilex	$5.81 +2.7%	$7.31	$4.20 ▼ $34.27	$49.73M	1.67	86,285 shs	5,457 shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DVLT Datavault AI	-1.91%	-2.44%	-12.51%	-36.69%	-25.15%
IBM International Business Machines	-2.16%	+1.11%	+7.89%	-8.20%	-4.40%
NMHI Nature's Miracle	+20.00%	+20.00%	-25.00%	-81.82%	-99.68%
SCLX Scilex	-1.22%	-11.56%	-17.25%	-11.70%	-70.01%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DVLT Datavault AI	$0.32 +0.8%	$0.35	$0.25 ▼ $4.10	$299.17M	0.31	48.05 million shs	4.63 million shs
IBM International Business Machines	$232.48 +0.6%	$246.44	$199.19 ▼ $332.46	$218.85B	0.7	7.94 million shs	534,145 shs
NMHI Nature's Miracle	$0.00	$0.00	$0.00 ▼ $0.46	$503K	0.68	24.80 million shs	4.88 million shs
SCLX Scilex	$5.81 +2.7%	$7.31	$4.20 ▼ $34.27	$49.73M	1.67	86,285 shs	5,457 shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DVLT Datavault AI	-1.91%	-2.44%	-12.51%	-36.69%	-25.15%
IBM International Business Machines	-2.16%	+1.11%	+7.89%	-8.20%	-4.40%
NMHI Nature's Miracle	+20.00%	+20.00%	-25.00%	-81.82%	-99.68%
SCLX Scilex	-1.22%	-11.56%	-17.25%	-11.70%	-70.01%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DVLT Datavault AI	2.50	Moderate Buy	$2.50	693.65% Upside
IBM International Business Machines	2.54	Moderate Buy	$265.40	14.16% Upside
NMHI Nature's Miracle	0.00	N/A	N/A	N/A
SCLX Scilex	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest SCLX, NMHI, IBM, and DVLT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/19/2026	IBM International Business Machines	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy
8/10/2026	DVLT Datavault AI	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
8/5/2026	DVLT Datavault AI	Litchfield Hills Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$2.00
8/4/2026	DVLT Datavault AI	Litchfield Hills Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong-Buy
7/24/2026	IBM International Business Machines	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$303.00 ➝ $225.00
7/24/2026	IBM International Business Machines	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$255.00 ➝ $245.00
7/23/2026	IBM International Business Machines	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Market Perform	$270.00 ➝ $230.00
7/23/2026	IBM International Business Machines	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$270.00
7/23/2026	IBM International Business Machines	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Equal Weight	$293.00 ➝ $190.00
7/23/2026	IBM International Business Machines	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$288.00 ➝ $262.00
7/21/2026	IBM International Business Machines	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$230.00

(Data available from 8/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DVLT Datavault AI	$39.09M	7.65	N/A	N/A	$0.41 per share	0.77
IBM International Business Machines	$67.54B	3.24	$16.90 per share	13.76	$35.03 per share	6.64
NMHI Nature's Miracle	$9.99M	0.05	N/A	N/A	($9.06) per share	0.00
SCLX Scilex	$31.61M	1.56	N/A	N/A	($24.94) per share	-0.23

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DVLT Datavault AI	-$78.99M	-$0.92	N/A	2.42	N/A	-370.21%	-46.04%	-39.35%	N/A
IBM International Business Machines	$10.59B	$11.27	20.61	17.57	2.31	15.52%	35.65%	7.54%	10/21/2026 (Estimated)
NMHI Nature's Miracle	-$7.34M	-$0.47	N/A	N/A	N/A	-127.93%	N/A	-95.86%	N/A
SCLX Scilex	-$358.73M	-$49.70	N/A	N/A	N/A	-1,414.57%	N/A	-147.00%	9/2/2026 (Estimated)

Latest SCLX, NMHI, IBM, and DVLT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/2/2026	Q2 2026	SCLX Scilex	-$0.1813	N/A	N/A	N/A	$16.00 million	N/A
8/14/2026	Q2 2026	SCLX Scilex	-$0.1813	-$16.65	-$16.4687	-$16.65	$16.00 million	$7.64 million
7/22/2026	Q2 2026	IBM International Business Machines	$2.93	$2.93	N/A	$2.27	$17.46 billion	$17.16 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DVLT Datavault AI	N/A	N/A	N/A	N/A	N/A
IBM International Business Machines	$6.76	2.93%	+0.61%	59.98%	30 Years
NMHI Nature's Miracle	N/A	N/A	N/A	N/A	N/A
SCLX Scilex	N/A	N/A	N/A	N/A	N/A

Latest SCLX, NMHI, IBM, and DVLT Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/22/2026	IBM International Business Machines	quarterly	$1.69	2.87%	8/10/2026	8/10/2026	9/10/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DVLT Datavault AI	N/A	4.95	4.92
IBM International Business Machines	1.63	0.79	0.74
NMHI Nature's Miracle	N/A	0.41	0.24
SCLX Scilex	N/A	0.07	0.06

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DVLT Datavault AI	0.66%
IBM International Business Machines	58.96%
NMHI Nature's Miracle	94.56%
SCLX Scilex	69.67%

Insider Ownership

Company	Insider Ownership
DVLT Datavault AI	7.70%
IBM International Business Machines	0.27%
NMHI Nature's Miracle	6.50%
SCLX Scilex	4.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DVLT Datavault AI	40	949.73 million	876.60 million	N/A
IBM International Business Machines	286,800	942.13 million	939.59 million	Optionable
NMHI Nature's Miracle	12	837.64 million	1.07 million	N/A
SCLX Scilex	80	8.49 million	8.11 million	No Data

SCLX, NMHI, IBM, and DVLT Headlines

Recent News About These Companies

Scilex Holding Company (NASDAQ: SCLX) - Share Price and Research

August 18, 2026 | intelligentinvestor.com.auI

Scilex Establishes $20 Million Credit Facility for Vivasor

August 12, 2026 | tipranks.com

Scilex (NASDAQ:SCLX) Trading 0.9% Higher - Should You Buy?

July 31, 2026 | marketbeat.com

Scilex Announces Strategic Sale of Vivasor Preferred Shares

July 22, 2026 | tipranks.com

Scilex Holding Company

July 16, 2026 | cnn.com

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for ...

July 7, 2026 | finance.yahoo.com

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP

July 7, 2026 | globenewswire.com

Scilex Holding Company (SCLX) Stock Surges on $100M Investment Proposal from iHolding

July 6, 2026 | blockonomi.com

Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens Commence Trading on the Biconomy Exchange on July 6, 2026

July 6, 2026 | globenewswire.com

Scilex shares jump after securing $100 million strategic investment proposal (SCLX)

July 6, 2026 | msn.com

What's going on with Scilex Holding stock Monday?

July 6, 2026 | msn.com

Scilex secures major growth capital equity investment

July 6, 2026 | tipranks.com

Scilex Holding Company Announces Binding Term Sheet for $100 Million Strategic Investment from iHolding Group LLP

July 6, 2026 | quiverquant.comQ

Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP

July 6, 2026 | globenewswire.com

Scilex Pursues Major Bitcoin Acquisition via Term Sheet

June 29, 2026 | tipranks.com

Scilex Stockholders Approve Director Election and Equity Plan

June 24, 2026 | tipranks.com

Scilex Holding Company to List Dream Bowl Tokens on Biconomy Exchange Starting June 23, 2026

June 16, 2026 | quiverquant.comQ

Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens to List on Biconomy Exchange as Early as June 23, 2026

June 16, 2026 | globenewswire.com

Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders ...

June 12, 2026 | finance.yahoo.com

Scilex Holding Company Announces Dividend Payment Date for Semnur Pharmaceuticals Common Stock

June 12, 2026 | quiverquant.comQ

Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities

June 12, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

SCLX, NMHI, IBM, and DVLT Company Descriptions

Datavault AI NASDAQ:DVLT

$0.32 +0.00 (+0.80%)

As of 10:56 AM Eastern

Datavault AI Inc., a data sciences technology company, owns and operates data management and supercomputer platforms. It offers data technology and software solutions. The company was formerly known as WiSA Technologies, Inc. and changed its name to Datavault AI Inc. in February 2025. Datavault AI Inc. was incorporated in 2010 and is headquartered in Beaverton, Oregon.

International Business Machines NYSE:IBM

$232.48 +1.44 (+0.62%)

As of 10:57 AM Eastern

International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services worldwide. The company operates through Software, Consulting, Infrastructure, and Financing segments. The Software segment offers a hybrid cloud and AI platforms that allows clients to realize their digital and AI transformations across the applications, data, and environments in which they operate. The Consulting segment focuses on skills integration for strategy, experience, technology, and operations by domain and industry. The Infrastructure segment provides on-premises and cloud based server, and storage solutions, as well as life-cycle services for hybrid cloud infrastructure deployment. The Financing segment offers client and commercial financing, facilitates IBM clients' acquisition of hardware, software, and services. The company has a strategic partnership to various companies including hyperscalers, service providers, global system integrators, and software and hardware vendors that includes Adobe, Amazon Web services, Microsoft, Oracle, Salesforce, Samsung Electronics and SAP, and others. The company was formerly known as Computing-Tabulating-Recording Co. International Business Machines Corporation was incorporated in 1911 and is headquartered in Armonk, New York.

Nature's Miracle NASDAQ:NMHI

$0.0006 0.00 (0.00%)

As of 08/24/2026 03:47 PM Eastern

Nature's Miracle Holding Inc., an agriculture technology company, provides lighting and grow media products to growers in the controlled environment agriculture industry in the United States and Canada. The company offers LED fixtures; high pressure sodium and ceramic metal halide fixtures; and electronic ballasts and control boxes. It also designs, builds, and operates various indoor growing settings, including greenhouse and indoor-growing spaces. The company sells its products directly to wholesale CEA distributors. Nature's Miracle Holding Inc. is headquartered in Ontario, California.

Scilex NASDAQ:SCLX

$5.81 +0.15 (+2.69%)

As of 10:57 AM Eastern

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company is also developing three product candidates, including SP-102 (10 mg dexamethasone sodium phosphate viscous gel) (SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a Phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4% (SP-103), a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a Phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules) (SP-104), a novel low-dose delayed-release naltrexone hydrochloride, which has completed Phase 1 trials for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SCLX, NMHI, IBM, and DVLT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SCLX, NMHI, IBM, and DVLT Earnings

Compare Dividends

Latest SCLX, NMHI, IBM, and DVLT Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SCLX, NMHI, IBM, and DVLT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SCLX, NMHI, IBM, and DVLT Company Descriptions

Datavault AI NASDAQ:DVLT

International Business Machines NYSE:IBM

Nature's Miracle NASDAQ:NMHI

Scilex NASDAQ:SCLX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools